242 related articles for article (PubMed ID: 11585289)
41. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.
Rosenfeld M; VanDevanter DR; Ren CL; Elkin EP; Pasta DJ; Konstan MW; Morgan WJ;
Pediatr Pulmonol; 2015 Sep; 50(9):856-62. PubMed ID: 26086901
[TBL] [Abstract][Full Text] [Related]
42. Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis.
Dakin CJ; Pereira JK; Henry RL; Wang H; Morton JR
Pediatr Pulmonol; 2002 Jun; 33(6):475-82. PubMed ID: 12001282
[TBL] [Abstract][Full Text] [Related]
43. Lung Clearance Index (LCI) in Patients with Bronchiolitis Obliterans: A Preliminary Report and Comparison to Cystic Fibrosis Patients.
Gur M; Yaacoby-Bianu K; Ilivitzki A; Bar-Yoseph R; Nir V; Hakim F; Toukan Y; Bentur L
Lung; 2016 Dec; 194(6):1007-1013. PubMed ID: 27645685
[TBL] [Abstract][Full Text] [Related]
44. Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis.
Bayfield KJ; Douglas TA; Rosenow T; Davies JC; Elborn SJ; Mall M; Paproki A; Ratjen F; Sly PD; Smyth AR; Stick S; Wainwright CE; Robinson PD
Thorax; 2021 Dec; 76(12):1255-1265. PubMed ID: 33927017
[TBL] [Abstract][Full Text] [Related]
45. Chest computed tomography predicts the frequency of pulmonary exacerbations in children with cystic fibrosis.
Sanders DB; Li Z; Brody AS
Ann Am Thorac Soc; 2015 Jan; 12(1):64-9. PubMed ID: 25474182
[TBL] [Abstract][Full Text] [Related]
46. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
Schmitt-Grohé S; Zielen S
Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023
[TBL] [Abstract][Full Text] [Related]
47. Is an FEV
König P; Ner Z; Acton JD; Ge B; Hewett J
Clin Respir J; 2018 Aug; 12(8):2397-2403. PubMed ID: 29920961
[TBL] [Abstract][Full Text] [Related]
48. Submaximal exercise capacity in adolescent and adult patients with cystic fibrosis.
Ziegler B; Rovedder PM; Lukrafka JL; Oliveira CL; Menna-Barreto SS; Dalcin Pde T
J Bras Pneumol; 2007; 33(3):263-9. PubMed ID: 17906786
[TBL] [Abstract][Full Text] [Related]
49. Diffusion weighted imaging in cystic fibrosis disease: beyond morphological imaging.
Ciet P; Serra G; Andrinopoulou ER; Bertolo S; Ros M; Catalano C; Colagrande S; Tiddens HA; Morana G
Eur Radiol; 2016 Nov; 26(11):3830-3839. PubMed ID: 26873494
[TBL] [Abstract][Full Text] [Related]
50. Effect of posture on regional ventilation in children.
Davies H; Helms P; Gordon I
Pediatr Pulmonol; 1992 Apr; 12(4):227-32. PubMed ID: 1614748
[TBL] [Abstract][Full Text] [Related]
51. Relation between clinical and roentgenological scores and measures of lung function in cystic fibrosis, with special reference to pulmonary Xenon133 elimination.
Ericsson A; Strandvik B; Troell S; Freyschuss U
Clin Physiol; 1987 Aug; 7(4):275-82. PubMed ID: 3621865
[TBL] [Abstract][Full Text] [Related]
52. Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis.
Aurora P; Stanojevic S; Wade A; Oliver C; Kozlowska W; Lum S; Bush A; Price J; Carr SB; Shankar A; Stocks J;
Am J Respir Crit Care Med; 2011 Mar; 183(6):752-8. PubMed ID: 20935113
[TBL] [Abstract][Full Text] [Related]
53. [Cystic fibrosis in adults: inter- and intraobserver agreement for the Brasfield and Chrispin-Norman chest radiography scoring systems and correlation with clinical data and spirometry].
Gutiérrez V; Olivera MJ; Girón RM; Rodríguez-Salvanés F; Caballero P
Arch Bronconeumol; 2005 Oct; 41(10):553-9. PubMed ID: 16266668
[TBL] [Abstract][Full Text] [Related]
54. Decline in annual lung function in workers exposed to asbestos with and without pre-existing fibrotic changes on chest radiography.
Nakadate T
Occup Environ Med; 1995 Jun; 52(6):368-73. PubMed ID: 7627312
[TBL] [Abstract][Full Text] [Related]
55. Evidence of diminished FEV1 and FVC in 6-year-olds followed in the European Cystic Fibrosis Patient Registry, 2007-2009.
VanDevanter DR; Pasta DJ
J Cyst Fibros; 2013 Dec; 12(6):786-9. PubMed ID: 23632449
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary Impairment in Tuberculosis Survivors: The Korean National Health and Nutrition Examination Survey 2008-2012.
Jung JW; Choi JC; Shin JW; Kim JY; Choi BW; Park IW
PLoS One; 2015; 10(10):e0141230. PubMed ID: 26496500
[TBL] [Abstract][Full Text] [Related]
57. Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease?
Loeve M; Lequin MH; de Bruijne M; Hartmann IJ; Gerbrands K; van Straten M; Hop WC; Tiddens HA
Radiology; 2009 Oct; 253(1):223-9. PubMed ID: 19710003
[TBL] [Abstract][Full Text] [Related]
58. Comparison between magnetic resonance imaging and computed tomography of the lung in patients with cystic fibrosis with regard to clinical, laboratory, and pulmonary functional parameters.
Renz DM; Scholz O; Böttcher J; Maurer MH; Denecke T; Schwarz C; Pfeil A; Streitparth F; Huppertz A; Mehl A; Poellinger A; Staab D; Hamm B; Mentzel HJ
Invest Radiol; 2015 Oct; 50(10):733-42. PubMed ID: 26154442
[TBL] [Abstract][Full Text] [Related]
59. Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators.
Pennati F; Salito C; Borzani I; Cervellin G; Gambazza S; Guarise R; Russo MC; Colombo C; Aliverti A
Eur Respir J; 2019 May; 53(5):. PubMed ID: 30819810
[TBL] [Abstract][Full Text] [Related]
60. High resolution CT in cystic fibrosis--the contribution of expiratory scans.
Dorlöchter L; Nes H; Fluge G; Rosendahl K
Eur J Radiol; 2003 Sep; 47(3):193-8. PubMed ID: 12927662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
